Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by a lack of estrogen receptors, progesterone receptors, and human epithelial growth factor receptor 2, accounting for approximately 20% of all breast cancers (Yin et al., 2020). This evidence concerns the gene ESR1 and breast cancer.